Name: Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans (Video) | JoVE Journal
Uploaded: 2022-03-24T14:00:00.000+00:00
Duration: 4 min 48 s
Description: Learn rose bengal-mediated photodynamic therapy to inhibit multidrug-resistant Candida albicans using a custom green LED array and 96-well plate format. This method enables rapid assessment of antifungal efficacy.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

This work has received funding from the Center of Applied Nanomedicine, National Cheng Kung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE), and Ministry of Science and Technology, Taiwan [MOST 109-2327-B-006-005] to TW Wong. J.H. Hung acknowledges funding from National Cheng Kung University Hospital, Taiwan [NCKUH-11006018], and [MOST 110-2314-B-006-086-MY3].

1. aPDT system preparation
<ol>
	<li>Cut four green light-emitting diodes (LEDs) from a LED strip (see Table of Materials) and align them with four wells of a 96-well plate (Figure 1). 
	NOTE: The LEDs were arranged into a 4 x 3 array. The back of the LED was adhered to a heat sink to disperse heat during irradiation.</li>
	<li>Measure the fluence rate11 of the LED at 540 nm with a light power meter (see Table of Materials). See Supplementary Figure 1 to ensure that the fluence rate of the LED is between 510-560 nm.</li>
	<li>Put an electric fan alongside the plate during irradiation to maintain the constant temperature (25 &#177; 1 &#176;C)11. See Supplementary Figure 2 to ensure that the constant temperature of the medium is maintained during irradiation.</li>
</ol>
2. Culturing of the yeast form of&#160;&#160;C. albicans
NOTE: A multidrug-resistant C. albicans (BCRC 21538/ATCC 10231), resistant to most antifungals, including fluconazole, is used for the experiments16.
<ol>
	<li>Determine the antimycotic drug sensitivity with a disk diffusion method following previously published report17.</li>
	<li>Grow C. albicans in yeast, hyphae, and pseudohyphae forms depending on the micro-ecological environments18. 
	&#8203;NOTE: The hyphae and pseudohyphae forms are difficult for an accurate calculation. The yeast form can be calculated precisely under a microscope or with flow cytometry. The temperature during cell growth determines its morphology. At room temperature (25 &#176;C), nearly all cells are yeast form. A 4 h short incubation of C. albicans at 30 &#176;C did not affect its yeast morphology.</li>
</ol>
3. aPDT on planktonic&#160;&#160;C. albicans
<ol>
	<li>Isolate a single colony of C. albicans from an agar plate with a sterile loop and add it to a 3 mL yeast extract peptone dextrose (YPD) medium (see Table of Materials) in a sterilized glass tube.
	<ol>
		<li>Incubate the tube at 25 &#177; 1 &#176;C overnight (14-16 h) in an incubator with a rotation speed of 155 rpm to expand C. albicans and maintain the fungus in yeast form for accurate quantification.</li>
	</ol>
	</li>
	<li>Dilute the overnight culture with medium to an OD600 value of around 0.5 at 30&#176; C and rotate at a speed of 155 rpm for 4 h to achieve a log growth phase of C. albicans.</li>
	<li>Dilute the log phase culture again with fresh YPD medium to an OD600 value of 0.65 (around 1 x 107 colony forming units, CFU/mL). Confirm the final concentration by serial dilution method on an agar plate8.</li>
	<li>Prepare a stock solution (4%) of Rose bengal (RB) by dissolving the powder in 1x PBS. Filter and sterilize it with a 0.22 &#181;m filter and store it at 4 &#176;C in the dark. The final working concentration of RB is 0.2%.</li>
	<li>Add 111 &#181;L of 2% RB to 1 mL of log-phase&#160;C. albicans in a 1.5 mL microcentrifuge tube and co-culture at different time points (0, 15, and 30 min) at room temperature to understand the absorption of RB in the cells (Figure 2).</li>
	<li>Wash the co-culture three times with 1 mL of 1x PBS with centrifugation at 16,100 x g for 2.5 min at room temperature. 
	NOTE: aPDT contains four different conditions: absolute control (no light exposure, no RB), dark control (no light but incubates with RB), light control (exposes to light without RB), aPDT (exposes to light in the presence of RB).</li>
	<li>Resuspend the C. albicans in 1 mL of 1x PBS and allocate them into three different wells in a 96 well plate for each condition. Align the wells with the LED array after washing.</li>
	<li>In light exposed groups, turn on the electric fan and light. 
	&#8203;NOTE: A different fluence (J/cm2) can be achieved by exposing the wells to varying time periods. For example, a 16.7 min light exposure comes to 10 J/cm2 with a 10 mW/cm2 LED light bulb.</li>
	<li>After irradiation, add 20 &#181;L of the co-culture solution from one well to a 1.5 mL centrifuge tube containing 180 &#181;L of 1x PBS to prepare a 10x dilution. Further, dilute ten times, subsequently following the same method.</li>
	<li>Drop three drops of 20 &#181;L of each serial dilution onto one quadrant of a YPD agar plate to achieve countable colonies the plate. Calculate the CFU/mL by multiplying the colonies with the dilution factors3.</li>
</ol>
4. Statistical analysis
<ol>
	<li>Analyze the collected data using a graphing and statistics software (see Table of Materials).</li>
	<li>Depict data by mean &#177; standard error of the mean. Perform a two-way ANOVA analysis of variance8 to evaluate significant differences between the different test conditions.</li>
	<li>Perform Tukey&#39;s multiple comparison tests for pairwise comparisons8. For each different treatment, perform at least three independent experiments. Consider p-value &#60; 0.05 statistically significant.</li>
</ol>

<ol><li>Naglik, J. R., Challacombe, S. J., Hube, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Candida+albicans+secreted+aspartyl+proteinases+in+virulence+and+pathogenesis%5BTitle%5D)+AND+%22Microbiology+and+Molecular+Biology+Reviews%22%5BJournal%5D)">Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.</a> Microbiology and Molecular Biology Reviews. 67 (3), 400-428 (2003).</li>
<li>Pappas, P. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Clinical+practice+guideline+for+the+management+of+candidiasis%3A+2016+update+by+the+Infectious+Diseases+Society+of+America%5BTitle%5D)+AND+%22Clinical+Infectious+Diseases%22%5BJournal%5D)">Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.</a> Clinical Infectious Diseases. 62 (4), 1-50 (2016).</li>
<li>Ricotta, E. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Invasive+candidiasis+species+distribution+and+trends%2C+United+States%2C+2009-2017%5BTitle%5D)+AND+%22Journal+of+Infectious+Diseases%22%5BJournal%5D)">Invasive candidiasis species distribution and trends, United States, 2009-2017.</a> Journal of Infectious Diseases. 223 (7), 1295-1302 (2021).</li>
<li>Koehler, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Morbidity+and+mortality+of+candidaemia+in+Europe%3A+an+epidemiologic+meta-analysis%5BTitle%5D)+AND+%22Clinical+Microbiology+and+Infection%22%5BJournal%5D)">Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.</a> Clinical Microbiology and Infection. 25 (10), 1200-1212 (2019).</li>
<li>Toda, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Population-based+active+surveillance+for+culture-confirmed+candidemia+-+four+sites%2C+United+States%2C+2012-2016%5BTitle%5D)+AND+%22Morbidity+and+Mortality+Weekly+Report+Surveillance+Summaries%22%5BJournal%5D)">Population-based active surveillance for culture-confirmed candidemia - four sites, United States, 2012-2016.</a> Morbidity and Mortality Weekly Report Surveillance Summaries. 68 (8), 1-15 (2019).</li>
<li>Lee, C. N., Hsu, R., Chen, H., Wong, T. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Daylight+photodynamic+therapy%3A+an+update%5BTitle%5D)+AND+%22Molecules%22%5BJournal%5D)">Daylight photodynamic therapy: an update.</a> Molecules. 25 (21), 5195(2020).</li>
<li>Wainwright, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Photodynamic+antimicrobial+chemotherapy+%28PACT%29%5BTitle%5D)+AND+%22Journal+of+Antimicrobial+Chemotherapy%22%5BJournal%5D)">Photodynamic antimicrobial chemotherapy (PACT).</a> Journal of Antimicrobial Chemotherapy. 42 (1), 13-28 (1998).</li>
<li>Wong, T. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Indocyanine+green-mediated+photodynamic+therapy+reduces+methicillin-resistant+staphylococcus+aureus+drug+resistance%5BTitle%5D)+AND+%22Journal+of+Clinical+Medicine%22%5BJournal%5D)">Indocyanine green-mediated photodynamic therapy reduces methicillin-resistant staphylococcus aureus drug resistance.</a> Journal of Clinical Medicine. 8 (3), 411(2019).</li>
<li>Kim, M. M., Darafsheh, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Light+sources+and+dosimetry+techniques+for+photodynamic+therapy%5BTitle%5D)+AND+%22Photochemistry+and+Photobiology%22%5BJournal%5D)">Light sources and dosimetry techniques for photodynamic therapy.</a> Photochemistry and Photobiology. 96 (2), 280-294 (2020).</li>
<li>Wong, T. W., Sheu, H. M., Lee, J. Y., Fletcher, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Photodynamic+therapy+for+Bowen%27s+disease+%28squamous+cell+carcinoma+in+situ%29+of+the+digit%5BTitle%5D)+AND+%22Dermatologic+Surgery%22%5BJournal%5D)">Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit.</a> Dermatologic Surgery. 27 (5), 452-456 (2001).</li>
<li>Wong, T. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Photodynamic+inactivation+of+methicillin-resistant+Staphylococcus+aureus+by+indocyanine+green+and+near+infrared+light%5BTitle%5D)+AND+%22Dermatologica+Sinica%22%5BJournal%5D)">Photodynamic inactivation of methicillin-resistant Staphylococcus aureus by indocyanine green and near infrared light.</a> Dermatologica Sinica. 36 (1), 8-15 (2018).</li>
<li>Stasko, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Visible+blue+light+inhibits+infection+and+replication+of+SARS-CoV-2+at+doses+that+are+well-tolerated+by+human+respiratory+tissue%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue.</a> Scientific Reports. 11 (1), 20595(2021).</li>
<li>Crosbie, J., Winser, K., Collins, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mapping+the+light+field+of+the+Waldmann+PDT+1200+lamp%3A+potential+for+wide-field+low+light+irradiance+aminolevulinic+acid+photodynamic+therapy%5BTitle%5D)+AND+%22Photochemistry+and+Photobiology%22%5BJournal%5D)">Mapping the light field of the Waldmann PDT 1200 lamp: potential for wide-field low light irradiance aminolevulinic acid photodynamic therapy.</a> Photochemistry and Photobiology. 76 (2), 204-207 (2002).</li>
<li>Feenstra, R. P., Tseng, S. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comparison+of+fluorescein+and+rose+bengal+staining%5BTitle%5D)+AND+%22Ophthalmology%22%5BJournal%5D)">Comparison of fluorescein and rose bengal staining.</a> Ophthalmology. 99 (4), 605-617 (1992).</li>
<li>Demidova, T. N., Hamblin, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effect+of+cell-photosensitizer+binding+and+cell+density+on+microbial+photoinactivation%5BTitle%5D)+AND+%22Antimicrobial+Agents+and+Chemotherapy%22%5BJournal%5D)">Effect of cell-photosensitizer binding and cell density on microbial photoinactivation.</a> Antimicrobial Agents and Chemotherapy. 49 (6), 2329-2335 (2005).</li>
<li>Shahid, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Duclauxin+derivatives+from+fungi+and+their+biological+activities%5BTitle%5D)+AND+%22Frontiers+in+Microbiology%22%5BJournal%5D)">Duclauxin derivatives from fungi and their biological activities.</a> Frontiers in Microbiology. 12, 766440(2021).</li>
<li>Arendrup, M. C., Park, S., Brown, S., Pfaller, M., Perlin, D. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evaluation+of+CLSI+M44-A2+disk+diffusion+and+associated+breakpoint+testing+of+caspofungin+and+micafungin+using+a+well-characterized+panel+of+wild-type+and+fks+hot+spot+mutant+Candida+isolates%5BTitle%5D)+AND+%22Antimicrobial+Agents+and+Chemotherapy%22%5BJournal%5D)">Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.</a> Antimicrobial Agents and Chemotherapy. 55 (5), 1891-1895 (2011).</li>
<li>Mukaremera, L., Lee, K. K., Mora-Montes, H. M., Gow, N. A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Candida+albicans+yeast%2C+pseudohyphal%2C+and+hyphal+morphogenesis+differentially+affects+immune+recognition%5BTitle%5D)+AND+%22Frontiers+in+Immunology%22%5BJournal%5D)">Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition.</a> Frontiers in Immunology. 8, 629(2017).</li>
<li>Hung, J. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Recent+advances+in+photodynamic+therapy+against+fungal+keratitis%5BTitle%5D)+AND+%22Pharmaceutics%22%5BJournal%5D)">Recent advances in photodynamic therapy against fungal keratitis.</a> Pharmaceutics. 13 (12), 2011(2021).</li>
<li>Martinez, J. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rose+Bengal+photodynamic+antimicrobial+therapy%3A+a+pilot+safety+study%5BTitle%5D)+AND+%22Cornea%22%5BJournal%5D)">Rose Bengal photodynamic antimicrobial therapy: a pilot safety study.</a> Cornea. 40 (8), 1036-1043 (2021).</li>
</ol>

The authors declare no conflict of interest.

Encouraging results of clinical applications of RB-PDT for fungal keratitis have been reported recently19. The absorption peak of RB is at 450-650 nm. It is essential to determine the fluence rate of the light source for a successful aPDT. A high fluence (usually &#62;100 J/cm2) is required to treat cancer cells, while a lower fluence is expected to treat infected lesions6. A high fluence means a long exposure time which may not be practical in a clinical setting...

C. albicans colonizes in the gastrointestinal and genitourinary tracts of healthy individuals and can be detected as normal microbiota in about 50 percent of individuals1. If an imbalance is created between the host and the pathogen, C. albicans is capable of invading and causing disease. The infection can range from local mucous membrane infections to multiple organ failure2. In a multicenter surveillance study in the US, around half of the isolates from patients with invasive candidiasis between 2009 and 2017 is C. albicans3. Candidemia can be associated with high morbidity rates, mortality, prolonged hospital stay4. US Centers of Disease Control and Prevention reported that about 7% of all Candida blood samples tested are resistant to the antifungal drug fluconazole5. The emergence of drug-resistant Candida species raises the concern to develop an alternative or adjuvant therapy to antimycotic agents.
Antimicrobial photodynamic therapy (aPDT) involves activating a specific photosensitizer (PS) with light at the peak absorption wavelength of the PS6. After excitation, the excited PS transfers its energy or electrons to the nearby oxygen molecules and returns to the ground state. During this process, reactive oxygen species and singlet oxygen are formed and cause cell damage. aPDT has been widely used to kill microorganisms since the 1990s7. One of the benefits of aPDT is that multiple organelles are damaged in a cell by singlet oxygen and/or reactive oxygen species (ROS) during irradiation; thus, resistance to aPDT has not been found till today. Moreover, a recent study reported that the bacteria that survived after aPDT became more sensitive to antibiotics8.
The light sources used in aPDT include lasers, metal halogen lamps with filters, near-infrared light, and light-emitting diode (LED)9,10,11,12. The laser provides a high light power, usually larger than 0.5 W/cm2, that allows for the delivery of a high light dose in a very short time. It has been widely used in cases where a longer treatment time is inconvenient such as aPDT for oral infections. The drawback of a laser is that its spot size of illumination is small, ranging from a few hundred micrometers to 10 mm with a diffuser. Moreover, laser equipment is expensive and needs specific training to operate. On the other hand, the irradiation area of a metal halogen lamp with filters is relatively larger13. However, the lamp is too hefty and expensive. LED light sources have become mainstream of aPDT in the dermatologic field because it is small and less expensive. The irradiation area can be relatively large with an array arrangement of the LED light bulb. The whole face can be illuminated at the same time9. Nevertheless, most, if not all, LED light sources available today are designed for clinical use. It may not be suitable for experiments in a lab because it is space-occupying and expensive. We developed an inexpensive LED array that is very small and can be cut and assembled from a LED strip. The LEDs can be fitted into different arrangements for different experimental designs. Different conditions of aPDT can be completed in a 96-well plate or even a 384-well plate in one experiment.
Rose bengal (RB) is a colored dye widely used to enhance visualization of corneal damages in human eyes14. RB-mediated aPDT has shown killing effects on Staphylococcus aureus, Escherichia coli, and C. albicans with roughly comparable efficiency to that of Toluidine blue O15. This study demonstrates a method to validate the effect of RB-aPDT on multidrug-resistant C. albicans.

<table><tbody><tr><td>1.5 mL microfuge tube</td><td>Neptune, San Diego, USA</td><td>#3745.x</td><td></td></tr><tr><td>5 mL round-bottom tube with cell strainer cap</td><td>Falcon, USA</td><td>#352235</td><td></td></tr><tr><td>96-well plate</td><td>Alpha plus, Taoyuan Hsien, Taiwan</td><td>#16196</td><td></td></tr><tr><td>Aluminum foil</td><td>sunmei, Tainan, Taiwan</td><td></td><td></td></tr><tr><td>Aluminum heat sink</td><td>Nanyi electronics Co., Ltd., Tainan, Taiwan</td><td>BK-T220-0051-01</td><td>Disperses heat from the LED array.</td></tr><tr><td>Centrifuge</td><td>Eppendorf, UK</td><td>5415R</td><td></td></tr><tr><td>Graph pad prism software</td><td>GraphPad 8.0, San Diego, California, USA</td><td></td><td>graphing and statistics software</td></tr><tr><td>Green light emitting diode (LED) strip</td><td>Nanyi electronics Co., Ltd., Tainan, Taiwan</td><td>2835</td><td>Emission peak wavelength: 525 nm, Viewing angle: 150&amp;deg;; originated from https://www.aliva.com.tw/product.php?id=63</td></tr><tr><td>Incubator</td><td>Yihder, Taipei, Taiwan</td><td>LM-570D (R)</td><td></td></tr><tr><td>Light power meter</td><td>Ophir, Jerusalem, Israel</td><td>PD300-3W-V1-SENSOR,</td><td></td></tr><tr><td>Millex 0.22 &amp;mu;m filter</td><td>Merck, NJ, USA</td><td>SLGVR33RS</td><td></td></tr><tr><td>Multidrug-resistant Candida albicans</td><td>Bioresource Collection and Research CenterBioresource, Hsinchu, Taiwan</td><td>BCRC 21538/ATCC 10231</td><td>http://catalog.bcrc.firdi.org.tw/BcrcContent?bid=21538</td></tr><tr><td>OD&lt;sub&gt;600&lt;/sub&gt; spectrophotometer</td><td>Biochrom, London, UK</td><td>Ultrospec 10</td><td></td></tr><tr><td>Rose Bengal</td><td>Sigma-Aldrich, MO, USA</td><td>330000</td><td>stock concentration 40 mg/mL = 4%, prepare in PBS, stored at 4 &amp;deg;C</td></tr><tr><td>Sterilized glass tube</td><td>Sunmei Co., Ltd., Tainan, Taiwan</td><td>AK45048-16100</td><td></td></tr><tr><td>Yeast Extract Peptone Dextrose Medium</td><td>HIMEDIA, India</td><td>M1363</td><td></td></tr></tbody></table>

rose bengal-mediated photodynamic therapy to inhibit candida albicans

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Invasive Candida albicans infection is a significant opportunistic fungal infection in humans because it is one of the most common colonizers of the gut, mouth, vagina, and skin. Despite the availability of antifungal medication, the mortality rate of invasive candidiasis remains ~50%. Unfortunately, the incidence of drug-resistant C. albicans is increasing globally. Antimicrobial photodynamic therapy (aPDT) may offer an alternative or adjuvant treatment to inhibit C. albicans biofilm formation and overcome drug resistance. Rose bengal (RB)-mediated aPDT has shown effective cell killing of bacteria and C. albicans. In this study, the efficacy of RB-aPDT on multidrug-resistant C. albicans is described. A homemade green light-emitting diode (LED) light source is designed to align with the center of a well of a 96-well plate. The yeasts were incubated in the wells with different concentrations of RB and illuminated with varying fluences of green light. The killing effects were analyzed by the plate dilution method. With an optimal combination of light and RB, 3-log growth inhibition was achieved. It was concluded that RB-aPDT might potentially inhibit drug-resistant C. albicans.

Figure 1 shows the aPDT system being used in the present study. Since high temperatures may cause significant cell death, the LED array is cooled by an electric fan, and a heat sink is used during irradiation to maintain a constant temperature at 25 ± 1 °C. The heat effect can be discounted. Having an even light distribution is also an important determining factor for a successful aPDT; therefore, it is critical to align the LED light bulb to the well precisely during illumination. Due to th...

The growing incidence of drug-resistant Candida albicans is a serious health issue worldwide. Antimicrobial photodynamic therapy (aPDT) may offer a strategy to fight against drug-resistant fungal infections. The present protocol describes Rose bengal-mediated aPDT efficacy on a multidrug-resistant C. albicans strain in vitro.

Invasive Candida albicans infection is a significant opportunistic fungal infection in humans because it is one of the most common colonizers of the gut, ...

rose-bengal-mediated-photodynamic-therapy-to-inhibit-candida-albicans

Research

JoVE Journal

Immunology and Infection

Here, we present a protocol to assess the outcome of red light application on the growth of Candida albicans biofilm. A non-coherent red light device with the wavelength of 635 nm and energy density of 87.6 J·cm-2 was applied throughout the growth of Candida albicans biofilms for 48 h.

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

This protocol describes the application of antimicrobial Photodynamic Therapy (aPDT) in a murine model of oral candidiasis. aPDT was performed using a water-soluble mixture of curcuminoids and blue LED light.

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis

The significance of petite colonies in Candida spp. drug resistance has not been fully explored. Antimicrobial photodynamic therapy (aPDT) offers a promising strategy against drug-resistant fungal infections. This study demonstrates that rose bengal-mediated aPDT effectively deactivates Candida glabrata and induces petite colonies, presenting a unique procedure.

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

This manuscript presents a novel, innovative 3D-printed illumination device for studying Rose Bengal-mediated photodynamic therapy in vitro.

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

We describe a simple, rapid and robust method for the formation of Candida albicans biofilms using 96 well microtiter plates and its utility in antifungal susceptibility testing of cells within biofilms.

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Bacterial pyomelanin production results in increased resistance to oxidative stress and virulence. We report on techniques that can be used to determine inhibition of pyomelanin production and assay the resulting increase in sensitivity to oxidative stress in bacteria, as well as determine antibiotic minimum inhibitory concentration (MIC).

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

While in vitro study of host-pathogen interactions allow the characterization of specific immune responses, in vivo models are required to observe the effects of complex responses. Using Candida albicans exposure followed by Pseudomonas aeruginosa-mediated lung infection, we established a murine model of microbial interactions involved in ventilator-associated pneumonia pathogenicity.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Macrophages are plastic cells of the hematopoietic system that have a crucial role in protective immunity and homeostasis. In this report, we describe optimized in vitro techniques to phenotypically and functionally characterize graft-infiltrating regulatory macrophages that accumulate in the transplanted organ under tolerogenic conditions.

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

This protocol describes the use of a customizable automated microfluidic device to visualize biofilm formation in Candida albicans under host physiological conditions.

Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device

Here we describe a protocol that allows histological and molecular analysis of skin samples after Candida albicans intradermal injection. This protocol maintains the structural integrity of the skin and allows for the localization of tissue-resident or newly recruited immune cells as well as the pathogen distribution.

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Learn rose bengal-mediated photodynamic therapy to inhibit multidrug-resistant Candida albicans using a custom green LED array and 96-well plate format. This method enables rapid assessment of antifungal efficacy.

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Explore More Videos